Brokerages Set Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Price Target at $56.31

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) has been assigned an average recommendation of “Moderate Buy” from the eight research firms that are presently covering the stock, Marketbeat.com reports. Three analysts have rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 12-month price objective among brokerages that have updated their coverage on the stock in the last year is $56.31.

Several analysts recently issued reports on ACHC shares. Barclays downgraded Acadia Healthcare from an “overweight” rating to an “equal weight” rating and cut their price target for the stock from $43.00 to $35.00 in a report on Friday, February 28th. TD Cowen lowered their target price on Acadia Healthcare from $70.00 to $66.00 and set a “buy” rating on the stock in a research report on Tuesday, January 7th. KeyCorp lowered their target price on Acadia Healthcare from $70.00 to $65.00 and set an “overweight” rating on the stock in a research report on Monday, March 3rd. Bank of America lowered their target price on Acadia Healthcare from $50.00 to $44.50 and set a “buy” rating on the stock in a research report on Friday, February 28th. Finally, StockNews.com cut Acadia Healthcare from a “hold” rating to a “sell” rating in a research report on Monday, January 6th.

Acadia Healthcare Trading Up 1.3 %

Shares of NASDAQ ACHC opened at $28.54 on Wednesday. The company has a market cap of $2.65 billion, a price-to-earnings ratio of 9.36, a price-to-earnings-growth ratio of 1.46 and a beta of 1.38. Acadia Healthcare has a 12-month low of $27.61 and a 12-month high of $82.40. The company has a current ratio of 1.07, a quick ratio of 1.07 and a debt-to-equity ratio of 0.60. The stock’s 50 day simple moving average is $40.15 and its 200 day simple moving average is $48.73.

Hedge Funds Weigh In On Acadia Healthcare

Several hedge funds have recently modified their holdings of ACHC. FMR LLC increased its position in shares of Acadia Healthcare by 257.9% during the 4th quarter. FMR LLC now owns 6,230,631 shares of the company’s stock valued at $247,045,000 after purchasing an additional 4,489,681 shares during the period. Madison Avenue Partners LP acquired a new position in shares of Acadia Healthcare during the 4th quarter valued at $76,339,000. Sachem Head Capital Management LP acquired a new position in shares of Acadia Healthcare during the 4th quarter valued at $52,734,000. Wellington Management Group LLP increased its position in shares of Acadia Healthcare by 12.2% during the 3rd quarter. Wellington Management Group LLP now owns 11,658,253 shares of the company’s stock valued at $739,250,000 after purchasing an additional 1,266,384 shares during the period. Finally, Khrom Capital Management LLC bought a new stake in shares of Acadia Healthcare during the 4th quarter worth $49,602,000.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.